The Longevity Digest 05/05 - 05/11
I'm cutting through the noise in longevity and anti-aging podcasts so you don't have to.
Welcome to The Longevity Digest.
The field moves fast. Too fast for most of us to track every breakthrough, every protocol update, every researcher’s latest findings. That’s where this comes in.
I’ve curated specific shows that consistently deliver evidence-based insights you can actually use. Think less fluff, more substance. The kind of information that changes how you practice or how you live.
Got a podcast that’s been delivering gold? Send it my way. I’m always hunting for voices that push the field forward.
This Newsletter Is Sponsored By Casa de Sante.
Dr Onyx MD PhD’s Insights on this week’s episodes
The N-of-1 Imperative: Personalized Medicine Is No Longer Optional
The most urgent signal across this week’s episodes is a collective rejection of population-level medicine. On The Human Upgrade (#1425, “Why Are Hackers Microdosing ‘Sex Drugs’ Now?”), the case was made forcefully that the only defensible longevity framework is N-of-1 care anchored in multi-omics — a cascade from genomics through transcriptomics, proteomics, metabolomics, and down to the exposome. The takeaway is deceptively simple: the right intervention for the wrong patient at the wrong time is noise, not medicine.
This philosophy crystallized in three clinically distinct episodes. On The Human Upgrade (#1449, “CDC Director Jim O’Neill on Fixing America’s Broken Food Policy”), Acting CDC Director Jim O’Neill confirmed that federal dietary guidance is pivoting away from one-size-fits-all grain-centric, low-fat dogma toward whole foods, higher protein (1.2–1.6 g/kg/day), and individualized fat recommendations — backed by a $144M ARPA-H initiative to develop and FDA-validate causal biomarkers of aging as surrogate endpoints for longevity therapies. Meanwhile, on The Human Upgrade (#1461, “Eat These Foods + Spices for 8 Weeks to Get 3 Years Younger”), Dr. Kara Fitzgerald brought this personalization imperative to the epigenetic level: a pilot RCT demonstrated a >3-year reduction in biological age (Horvath clock) in just 8 weeks using a polyphenol-dense, methylation-supportive protocol, with nutrients — not exercise — emerging as the primary drivers. The clear strategic implication: clinicians who aren’t measuring epigenetic age or ordering fasting insulin, homocysteine, and hsCRP alongside routine labs (as argued in Health Longevity Secrets, “3 Blood Tests Your Doctor Skips”) are operating on an outdated map in a rapidly redrawn territory.
This Newsletter Is Sponsored By Casa de Sante.
For anyone on GLP-1 medications like Ozempic or Wegovy, Low FODMAP nutrition is non-negotiable. These medications can slow digestion and trigger bloating or nausea, so choosing gut-friendly products helps you stay comfortable while protecting muscle and metabolism. Physician-formulated by Dr Onyx MD PhD Certified in Obesity Management, this Low FODMAP lineup supports nutrient absorption, muscle defense, and overall digestive balance:
Premium Protein Powder (Vegan Vanilla, Whey Vanilla, or Whey Chocolate) – helps preserve lean muscle during weight loss
FODMAP Digestive Enzymes – improves absorption and reduces GI side effects
Advanced Probiotic + Prebiotic Synbiotic Formula – supports a balanced gut microbiome
Essential Vitamin & Mineral Complex – replenishes nutrients often depleted during rapid weight loss
Gentle Colon Cleanse + Probiotic Support – aids regular elimination without irritation
All formulas are low FODMAP, non-GMO, and third-party tested—the ideal foundation for GLP-1 users focused on digestive comfort, metabolic health, and muscle preservation.
Because hormones and skin health are deeply connected, Dr Onyx MD PhD science-backed skincare supports barrier repair, hydration, and inflammation balance for healthy, resilient skin—especially during menopause or while using GLP-1 medications, when collagen loss and dryness can accelerate:
HydraLift Collagen Complex – firms and smooths for youthful elasticity
Antioxidant C+E Ferulic Radiance Serum – brightens and defends against oxidative stress
Needle-Free Wrinkle Smoother – softens fine lines without irritation
Ultra Retinol 10x + Bakuchiol Serum – boosts cell turnover with gentle plant retinol
Advanced Retinol Eye Repair – targets puffiness and under-eye wrinkles
Cellular Repair Growth Factor Peptides Serum – rejuvenates and supports skin repair
Advanced Neck Lift Firming Complex – improves tone and texture along the jawline and neck
Even Tone Brightening Cream – evens discoloration for radiant, balanced skin
Dr Onyx Adegbola MD PhD
Track Smarter. Eat Better. Thrive. Download the GLP1 Support App at https://casadesante.com/pages/app-glp-1-support-by-dr-onyx-md-phd
The Inflammation Axis: From Your Gut to Your Garage
A second powerful convergence this week was inflammation — specifically, the underappreciated sources of it. The conversation has expanded well beyond diet and sedentary behavior to include the built environment itself. On The Human Upgrade (#1444, “Your AC Is Making You Dumber”), Dave Asprey and the SuperStratum team made a compelling case that mycotoxins from water-damaged buildings and HVAC systems — fat-soluble mitochondrial poisons like ochratoxin A and zearalenone — are silent drivers of neurocognitive decline, endocrine disruption, and immune dysregulation. Critically, roughly 28% of people carry HLA-DR4 variants that impair mycotoxin clearance, explaining why one family member is debilitated while another is fine.
This environmental angle connects directly to the nervous system. On The Human Upgrade (#1425), vagal nerve stimulation was highlighted as a high-leverage tool that activates the cholinergic anti-inflammatory pathway (via α7nAChR/JAK-STAT/NF-κB) to suppress the NLRP3 inflammasome — a central orchestrator of systemic inflammation and fibrosis — with EGCG cited as an accessible adjunct. Complementing this, Huberman Lab’s episode with Dr. Dacher Keltner (”Cultivating Awe & Emotional Connection in Daily Life”) offered an unexpected ally in the fight against chronic inflammation: awe. An 8-week “awe walk” protocol demonstrated increased vagal tone (HRV), reduced inflammatory markers, and lower physical pain in older adults — a free, scalable intervention with a growing evidence base that deserves serious clinical consideration. The broader message: inflammation is a systems-level problem requiring systems-level thinking, from your HVAC filter to your afternoon walk.
The Pharmaceutical Crossroads: What the GLP-1 Era Is Really Teaching Us
Perhaps the most strategically important thread this week was the maturing, nuanced conversation around pharmacology in longevity — particularly the GLP-1 class and longevity staples like metformin and rapamycin. The message from multiple episodes is the same: drugs are adjuncts, not architectures. On The Human Upgrade (#1453, “Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie”), Dr. Jason Fung reframed obesity as a disorder of hunger biology — driven by hedonic and conditioned appetite amplified by ultra-processed foods and ubiquitous eating cues — rather than a simple caloric equation. He positioned GLP-1s as useful tools for suppressing appetite, but argued that durable results require concurrent behavioral and nutritional rewiring; otherwise, relapse is almost guaranteed when the medication stops.
On The Second Opinion Podcast (EP 118, “Navigating New GLP-1 Costs and Pharmacist Consultations”), the access barrier is breaking down: Medicare Part D launches a Bridge Program in July 2026 with an estimated $50/month copay for eligible patients, and branded GLP-1 prices have already fallen dramatically. Yet the most important signal for clinicians came from Lifespan with Dr. David Sinclair (”What To Do For Longevity”), where Sinclair explicitly grounded even the most sophisticated longevity molecules — NMN, resveratrol, metformin — within a behavioral architecture of 16:8 time-restricted eating, Mediterranean-pattern nutrition, and combined aerobic and resistance training, all of which convergently activate AMPK/mTOR/sirtuin pathways. Metformin’s potential for mitochondrial blunting and VO₂ max suppression was flagged (The Human Upgrade #1425), and the PEARL trial for rapamycin is still maturing. The bottom line: before reaching for the prescription pad, the most evidence-dense longevity intervention stack is still the oldest — eat well, move hard, sleep long, and reduce systemic inflammatory load. Pharmacology amplifies this foundation; it does not replace it.
This weeks episodes:
1. The Human Upgrade: Biohacking for Longevity & Performance
Why Are Hackers Microdosing “Sex Drugs” Now? : 1425
Published: 2026-03-03
URL: Listen Here
Summary
This episode advocates for precision medicine that integrates multi-omic data, autonomic modulation, and targeted therapeutics to optimize longevity. It highlights vagal nerve stimulation’s ability to downregulate the NLRP3 inflammasome, the need to individualize drugs and peptides, and the centrality of vascular tone/perfusion and mitochondrial function to healthy aging. Some claims are anecdotal and product-related; specific study details were not always provided in the discussion.
Key Takeaways
Precision medicine should move beyond one-size-fits-all epidemiology to N-of-1 care using multi-omics (genomics → transcriptomics → proteomics → metabolomics/exposome) to match the right intervention to the right person at the right time.
Vagal nerve stimulation engages the cholinergic anti-inflammatory pathway (α7nAChR/JAK–STAT/NF-κB) and can downregulate the NLRP3 inflammasome, a central driver of systemic inflammation and fibrosis; simple adjuncts like EGCG may also modulate NLRP3 activity.
Longevity pharmacology must be individualized: metformin is not universally beneficial (mitochondrial blunting/VO2 max concerns), rapamycin safety data are emerging (PEARL trial) but endpoints matter, and low-dose, pathway-targeted use of drugs and peptides (e.g., BPC-157, KPV, CJC-1295 with ipamorelin, PT-141) can have bioregulatory effects when used judiciously.
Vascular tone and perfusion are foundational to brain and sexual health; strategies include nitric oxide support, selective PDE5 inhibitor use (e.g., low-dose tadalafil in appropriate patients), and device-based approaches like acoustic shockwave therapy, which may promote neovascularization and lower MMP-9.
Actionable biomarkers beyond routine labs that inform aging biology include homocysteine, ApoB, Lp(a), TGF-β1, MMP-9, and C4a; pairing these with mitochondrial/energy-oriented interventions (IHHT, photobiomodulation, PEMF, HBOT) and exposome assessment can improve outcomes while AI can help sequence interventions efficiently.
Clinical Insight
Targeting autonomic balance and inflammatory set-points—specifically via vagal nerve stimulation to suppress NLRP3—combined with multi-omic profiling provides a practical, high-leverage way to personalize longevity care beyond traditional risk-factor management.
Actionable Takeaway
In patients with chronic inflammation or dysautonomia, add MMP-9 and homocysteine (along with ApoB, Lp(a), TGF-β1, and C4a when feasible) to baseline labs; if elevated, trial a noninvasive vagal nerve stimulation protocol to engage the cholinergic anti-inflammatory pathway and reassess biomarkers after 6–8 weeks.
2. The Human Upgrade: Biohacking for Longevity & Performance
Why Are Hackers Microdosing “Sex Drugs” Now? : 1425
Published: 2026-03-03
URL: Listen Here
Summary
This episode explores how precision medicine leverages multi-omics, exposome assessment, and autonomic modulation to individualize care, with practical discussion of peptides, low-dose pharmaceuticals (e.g., tadalafil), and advanced biomarkers beyond standard panels. The conversation emphasizes sequencing interventions for mitochondrial and vascular health, measuring transcriptomic responses to confirm epigenetic effects, and safeguarding data as personalized platforms mature.
Key Takeaways
Precision medicine requires an N-of-1, multi-omic approach (genomics, transcriptomics, proteomics, epigenetics, metabolomics, exposomics) to match the right intervention to the right person at the right time.
Autonomic modulation, particularly vagal nerve stimulation, can downregulate inflammatory pathways (e.g., NLRP3 inflammasome via the cholinergic anti-inflammatory pathway) and may improve longevity-relevant markers; EGCG was cited as a practical adjunct.
Microdosing or low-dose use of select pharmaceuticals (e.g., tadalafil for vascular tone) and emerging peptide therapeutics (e.g., BPC-157, KPV, CJC-1295 with ipamorelin/semorelin, PT-141) can be useful for targeted outcomes but should be sequenced thoughtfully; metformin and rapamycin are not universal longevity solutions.
Beyond routine labs, clinicians should consider biomarkers that reflect inflammation and vascular health such as homocysteine, MMP-9, TGF-β1, C4a, nitric oxide-related function, and even cell membrane lipidomics; low cerebral perfusion is common and clinically meaningful.
Biohacking technologies (e.g., intermittent hypoxic–hyperoxic training, photobiomodulation, PEMF, HBOT, acoustic shockwave) can be potent when applied in the right order and tracked with objective data; data privacy and ownership matter as multi-omic and exposome assessments scale.
Clinical Insight
Shifting from population averages to multi-omic, N-of-1 care—while actively modulating the autonomic nervous system—allows physicians to directly influence and verify changes in key inflammatory and vascular pathways (e.g., NLRP3, nitric oxide biology), improving precision and efficiency of interventions.
Actionable Takeaway
For patients with chronic inflammation, dysautonomia, or low perfusion, implement daily noninvasive vagal nerve stimulation (or paced-breathing/HRV training) for 10–20 minutes and track CRP/IL-6 and symptom changes; consider adding a well-tolerated green tea extract providing 200–400 mg EGCG/day as an NLRP3-modulating adjunct, checking for drug–supplement interactions.
3. The Human Upgrade: Biohacking for Longevity & Performance
Your AC Is Making You Dumber : 1444
Published: 2026-04-03
URL: Listen Here
Summary
This episode argues that air-conditioning and water‑damaged indoor environments expose occupants to mycotoxins that impair mitochondrial function, cognition, hormones, metabolism, and sleep, with variable susceptibility driven partly by HLA‑DR genetics. The hosts outline a cost‑conscious, stepwise approach to ‘detoxing’ homes and vehicles—fix moisture/HVAC, oxidize/degrade mycotoxins and VOCs, reseed with environmental probiotics, and protect high‑risk surfaces—alongside humidity and dust control. Limitations: many claims are experiential or product‑specific and not independently detailed in the episode; clinicians should interpret promotional elements cautiously and corroborate with evidence-based resources.
Key Takeaways
Toxic mold and their mycotoxins (e.g., ochratoxin A, zearalenone) are fat‑soluble mitochondrial poisons that can drive multisystem illness—neurocognitive deficits, sleep disturbance with vivid nightmares, mood/behavior changes, endocrine disruption (thyroid, estrogen dominance), weight gain, easy bruising, recurrent infections, and chemical sensitivity.
Susceptibility varies widely; genetics (e.g., HLA‑DR4 variants) and exposure history modulate risk, so one family member may be severely affected while others appear well. Brain SPECT data (Amen Clinics) suggest mold exposure can reduce prefrontal activity and cognition but may be reversible after remediation.
Built environments—especially HVAC systems, ductwork, dust, moisture-prone areas, and vehicles—are common and underrecognized exposure sources; ingestion via mold‑prone foods (coffee, grains, peanuts) also contributes.
Effective management pairs medical care with environmental strategies: identify and fix moisture sources, control indoor humidity (~40–50%), address HVAC and duct contamination, reduce dust, and consider staged decontamination (oxidizing fog/gas to degrade mycotoxins and VOCs, reseeding with environmental probiotics, and protective coatings on high‑risk surfaces).
Porous belongings can carry residual mycotoxins between homes; moving without decontaminating contents often perpetuates illness. Vehicles (cars/RVs) can be significant sources due to mold and VOCs; targeted ‘detox’ is different from standard detailing.
Clinical Insight
In patients with persistent, unexplained multisystem symptoms (fatigue/brain fog, sleep disruption, mood/behavior changes, weight dysregulation, chemical sensitivity), assessing and treating the home/vehicle environment—especially moisture control and HVAC/dust contamination—can be decisive for recovery from mycotoxin-related illness.
Actionable Takeaway
Screen for water‑damaged building exposure in symptomatic patients and recommend a basic home assessment: measure/maintain indoor humidity at 40–50%, use HEPA air filtration and HEPA vacuuming to reduce dust, inspect/clean HVAC and ducts, and initiate validated environmental testing (e.g., dust-based mycotoxin or ERMI/HERTSMI‑2) before escalating medications.
4. The Human Upgrade: Biohacking for Longevity & Performance
Your AC Is Making You Dumber : 1444
Published: 2026-04-03
URL: Listen Here
Summary
Dave Asprey and the SuperStratum team discuss how indoor mold and residual mycotoxins can impair mitochondrial function and contribute to wide-ranging symptoms, with variable patient susceptibility. They outline practical, staged approaches for homes and vehicles—addressing moisture control, HVAC/duct hygiene, dust removal, and targeted decontamination of mycotoxins/VOCs—to complement or follow traditional remediation.
Key Takeaways
The episode centers on indoor mold and mycotoxins as underrecognized drivers of diverse symptoms (fatigue, brain fog, sleep disturbance, mood changes, endocrine disruption, weight gain) via mitochondrial dysfunction and immune dysregulation.
Susceptibility varies widely; about 28% of people may carry HLA-DR4 variants associated with heightened inflammatory responses and reduced ability to clear fat-soluble mycotoxins, which helps explain why household members can be affected differently.
Common exposure sources include water-damaged buildings, high indoor humidity, HVAC/ductwork, dust accumulation, and vehicles; ochratoxin A (OTA) and zearalenone are highlighted as clinically relevant mycotoxins with thyroid and estrogenic effects, respectively.
Post-remediation illness can persist due to residual mycotoxins and VOCs on surfaces and in contents; the discussion emphasizes whole-home strategies: fix moisture sources, maintain 40–50% indoor RH, clean/coat HVAC and ducts, HEPA vacuum dust, and consider targeted decontamination approaches.
The guests discuss a staged approach they use (fogging/‘bombing’ to oxidize mycotoxins/VOCs, followed by environmental probiotics and durable anti-microbial coatings) as a lower-cost adjunct to traditional remediation, and note cars can require similar detox protocols.
Clinical Insight
In patients with otherwise unexplained neurocognitive, endocrine, sleep, or cardiometabolic complaints—especially with a history of dampness or water damage—environmental mycotoxin exposure is a plausible, often overlooked contributor; assessing susceptibility, the built environment (not just visible mold), and residual mycotoxins after remediation can materially influence outcomes.
Actionable Takeaway
Incorporate a brief environmental history and screening into visits for chronic, multisystem complaints: ask about water damage/musty odors, humidity levels, HVAC maintenance, visible condensation, dust burden, and car exposures; advise maintaining indoor RH ~40–50%, fixing moisture intrusions, HEPA vacuuming dust, servicing/cleaning HVAC and ducts, and consider referral to qualified mold assessment/remediation when indicated.
5. Huberman Lab
Cultivating Awe & Emotional Connection in Daily Life | Dr. Dacher Keltner
Published: 2026-04-06
URL: Listen Here
Summary
This episode details the science of awe—how shifting from narrow to vast perception, engaging with nature and music, and synchronizing in groups reliably evokes awe with tangible benefits across inflammation, vagal tone, pain, and well-being. Practical protocols (e.g., awe walks) offer clinicians scalable tools to augment care, while insights on social bonding (embarrassment/teasing) and carefully supervised psychedelic-assisted therapy highlight additional pathways to strengthen connection and resilience. Note: Some findings (e.g., long COVID improvements from brief daily awe) are preliminary and require further peer-reviewed validation.
Key Takeaways
Awe is a measurable, health-relevant state linked to increased vagal tone (HRV), reduced inflammation, lower physical pain, and reported improvement in long COVID symptoms from brief daily awe practices.
Shifting perceptual “aperture” from small to vast (for example, moving from focusing on a leaf to the canopy to the sky/horizon) reliably evokes awe and can recalibrate arousal, time perception, and self-focus toward equanimity.
An 8-week, once-weekly 20–30 minute “awe walk” intervention in older adults increased awe, kindness, and vast attention in daily life and reduced bodily pain, with longer-term follow-up suggesting brain health benefits.
Group synchrony (music, sport, dance, chanting, shared rituals) rapidly fosters bonding and collective identity, consistent with the concept of collective effervescence; embarrassment and prosocial teasing within groups signal commitment to norms and strengthen cohesion.
Psychedelics (classic serotonergic agents) can induce profound awe and may aid treatment-resistant conditions (e.g., end-of-life anxiety, depression, PTSD) when used in structured, safe, culturally respectful settings; microdosing lacks strong clinical evidence.
Clinical Insight
Awe can be deliberately elicited (nature, music, horizons, group synchrony) and functions as a low-cost, low-risk adjunct that measurably improves autonomic balance (vagal tone), reduces inflammatory load and pain, and supports mental health—making it a viable element to integrate into preventive care and rehabilitation plans.
Actionable Takeaway
Prescribe a weekly 20–30 minute awe walk for 8 weeks: ask patients to slow their pace and breath (prolonged exhalations), and to move attention from small to vast (e.g., a leaf → tree → treeline → clouds/horizon). Encourage one brief daily “micro-awe” (≈60 seconds via nature, music, or vistas). Track simple outcomes (pain ratings, mood/sleep, HRV if available) and consider adding music- or nature-based sessions for reinforcement.
6. Huberman Lab
Essentials: The Biology of Aggression, Mating & Arousal | Dr. David Anderson
Published: 2026-04-09
URL: Listen Here
Summary
This episode reviews the neurobiology of internal states governing aggression, mating, and arousal, emphasizing hypothalamic circuit logic, hormone signaling (notably estrogen pathways), and brain–body interactions. It highlights how social isolation engages conserved tachykinin mechanisms that amplify aggression and anxiety, suggesting concrete translational avenues (e.g., NK3 antagonists) while underscoring the clinical need to assess and address isolation.
Key Takeaways
Emotions are best understood as internal brain states (like arousal or motivation) that reshape input–output transformations of neural circuits; unlike reflexes, they often persist beyond the trigger and generalize across contexts.
Aggression is a heterogeneous set of behaviors supported by distinct but adjacent hypothalamic circuits (VMHvl): fear-related neurons can hierarchically suppress offensive aggression, and VMH integrates multisensory inputs while broadcasting low-dimensional ‘attack pressure’ signals widely.
Sex hormones do not map simply onto behavior: estrogen receptor–expressing neurons in male VMH are necessary for aggression, many testosterone effects are mediated via aromatization to estrogen, and in females, discrete VMH ER+ neuron subsets differentially control mating versus fighting.
Mating and aggression circuits exhibit reciprocal control: activating medial preoptic area (MPOA) ‘mating’ neurons can abruptly switch a male from fighting to courtship, whereas VMHvl ‘aggression’ neurons bias toward attack; PAG acts as a downstream ‘switchboard’ coordinating pain modulation and innate action patterns.
Social isolation robustly upregulates tachykinin signaling (e.g., tachykinin 2) across species, increasing aggression, fear, and anxiety; in mice, an NK3 receptor antagonist (osanotont) reverses isolation-induced phenotypes without sedation, highlighting a translational target for isolation-related psychopathology.
Clinical Insight
Social isolation is a potent, biologically mediated driver of negative affect and aggression—partly via tachykinin 2 signaling—with preclinical evidence that NK3 receptor antagonism can normalize isolation-induced aggression, fear, and anxiety without sedation; clinicians should treat isolation as a modifiable risk factor rather than a benign social state.
Actionable Takeaway
Routinely screen patients for social isolation (e.g., recent bereavement, living alone, limited social contact) and implement mitigation strategies—structured social engagement, therapy referrals, family/caregiver involvement, and follow-up touchpoints—especially in individuals showing increased irritability, anxiety, or aggression.
7. Huberman Lab
Essentials: The Biology of Aggression, Mating & Arousal | Dr. David Anderson
Published: 2026-04-09
URL: Listen Here
Summary
This episode synthesizes neural circuit, hormonal, and neuropeptide mechanisms underlying aggression, mating, arousal, and pain modulation. Key themes include hypothalamic control of offensive aggression and its suppression by fear, estrogenic regulation of male aggression, sex-specific VMH circuits for mating vs fighting, and tachykinin-driven effects of social isolation that are reversible with NK3R antagonism—findings with clear translational relevance for stress-related behavioral health.
Key Takeaways
Emotions are best understood as internal brain states (like arousal, motivation, sleep) that transform how inputs map to outputs; compared to reflexes, emotion states show persistence and generalization beyond the initial trigger.
Aggression is a behavior that can arise from different internal states (e.g., anger, fear, hunger); in mice, ventromedial hypothalamus (VMHvl) circuits drive offensive, positively valenced aggression, while adjacent hypothalamic fear circuits can hierarchically suppress fighting.
Hormonal control of aggression in males depends critically on estrogen receptor–expressing VMH neurons and aromatization of testosterone to estrogen; estrogen implants can restore aggression in castrated male mice.
Sex-specific neural architecture shapes behavior: in females, distinct estrogen receptor–positive VMH subsets separately control mating and fighting, and medial preoptic area (MPOA) ‘mating’ neurons can acutely suppress ongoing aggression (antagonistic VMH–MPOA interactions).
Social isolation upregulates tachykinin signaling (Tac2/neurokinin B) across the brain to increase aggression, fear, and anxiety; an NK3 receptor antagonist (osanetant) reverses these effects in mice. The periaqueductal gray (PAG) acts as a hub for innate behaviors and supports endogenous, state-dependent analgesia (e.g., during fear/defense).
Clinical Insight
Chronic social isolation induces a Tac2/NK3R-mediated, druggable brain state that heightens aggression, fear, and anxiety—highlighting both the clinical importance of assessing isolation/bereavement and the translational potential of NK3 receptor antagonism for stress-related behavioral dysregulation.
Actionable Takeaway
Routinely screen patients experiencing prolonged social isolation or bereavement for irritability, aggression, and anxiety, and implement structured social reconnection strategies (e.g., group therapy, regular follow-ups, community engagement) to mitigate these biologically primed risk states.
8. The Human Upgrade: Biohacking for Longevity & Performance
Why Doctors Can’t Fix Women in 2026 : 1446
Published: 2026-04-09
URL: Listen Here
Summary
This episode argues that modern care under-treats women’s hormones and that personalized, bioidentical HRT—especially estradiol and progesterone delivered vaginally at systemic doses—can be a cornerstone for restoring libido, cognition, mood, sleep, gut/gallbladder function, and overall vitality. The guests emphasize treating to clinical response (not just numbers), considering genetics and neurotransmitters, and leveraging nutrition (adequate protein, cautious fiber, iodine) while using testosterone judiciously. Note: Many claims were experiential and not directly cited; sponsor content and controversial viewpoints are included.
Key Takeaways
Personalized, bioidentical hormone replacement (estradiol, progesterone, ± testosterone) is presented as foundational for many symptomatic women—even premenopausally—with dosing guided by symptoms and function rather than fixed lab ‘norms’ or low-dose patches/pills.
Systemic vaginal delivery of estradiol and progesterone is advocated as higher bioavailability than oral/topical/patch routes, aiming to suppress elevated FSH and improve cognition, sleep, mood, gut/gallbladder function, and sexual function; oral progesterone’s sedating effects may arise from liver-derived metabolites.
Testosterone can benefit women’s libido and cognition but excess transdermal/injected T may increase DHT/aromatization or disrupt the vaginal microbiome; many women may normalize T by optimizing progesterone, with optional low-dose topical T for event-based arousal.
Diet and environment meaningfully influence hormones and neurotransmitters: prioritize adequate protein (supporting dopamine/COMT), avoid excessive insoluble fiber and certain phytoestrogens, consider iodine repletion for breast/uterine health, and be mindful of high-oxalate foods (e.g., matcha/spinach) implicated in kidney stones and tissue symptoms.
Evaluate and treat holistically: use FSH and symptom clusters to detect early dysfunction, recognize genetic/epigenetic differences (e.g., COMT) in hormone clearance, consider neurotransmitter support (dopamine/norepinephrine/serotonin), and avoid focusing on thyroid alone when sex-hormone deficits drive multi-system complaints.
Clinical Insight
For women with multi-system symptoms (mood, sleep, gut, libido, cognitive), adequately dosed, bioidentical estradiol plus progesterone—preferably via systemic vaginal delivery—and personalized titration to clinical response can restore function across brain, immune, gut, and sexual domains; labs (including FSH) inform but should not replace symptom-guided care.
Actionable Takeaway
In an appropriate symptomatic woman (even <45), obtain FSH, estradiol, progesterone, total/free testosterone, SHBG, DHEA-S, and thyroid panel; if findings and history suggest ovarian under-function, initiate a trial of bioidentical estradiol + progesterone via systemic vaginal delivery and titrate every 6–8 weeks to symptom relief while reinforcing adequate protein intake and avoiding excessive insoluble fiber.
9. The Human Upgrade: Biohacking for Longevity & Performance
Superhuman Contact Lenses, Motivation Supplement Stack, Cat Scratches Cause Brain Fog, Amino Acid Shortening Lifespan, and more... : 1448
Published: 2026-04-10
URL: Listen Here
Summary
This episode highlights overlooked inputs—stealth infections, amino acid balance, sensory light processing, micronutrient status, and olfactory cues—that materially affect cognition, motivation, and autonomic tone. It offers practical steps clinicians can use now: targeted PCR testing for Bartonella, judicious lab monitoring around tyrosine, nutrient stacking to bolster motivation, and low-cost sensory strategies to reduce cognitive and stress load.
Key Takeaways
Cat scratches/bites can transmit Bartonella, a stealth infection linked to chronic brain fog, mood instability, and fatigue; standard serology often misses it—PCR testing is preferred and may require referral to a Lyme-literate clinician.
A Mendelian randomization analysis (~270,000 participants) associates higher circulating tyrosine with nearly one year shorter lifespan in men (not women), potentially via myeloperoxidase-driven formation of inflammatory meta-tyrosine; consider measuring plasma tyrosine and phenylalanine and avoiding unnecessary tyrosine supplementation, especially in men.
Tinted contact lenses (Altius) reportedly reduce chromatic aberration by 53% and improve contrast by 20–30%, potentially lowering visual processing load and enhancing performance; spectrum-filtering eyewear (e.g., TrueDark) and screen apps (Flux/Iris) are adjuncts.
A randomized, placebo-controlled crossover trial from the University of the Philippines found a 4-week stack (taurine 2 g, methylfolate 800 mcg, P5P 50 mg, methylcobalamin 1 mg) increased effort-based motivation and reduced attention lapses, plausibly via astrocytic glutathione support of prefrontal function.
A Monell Chemical Senses Center analysis indicates a 30-second deep nasal inhalation of floral scents can lower heart rate by 5–10 bpm and shift autonomic tone toward parasympathetic; lavender has the strongest RCT support, but pleasant florals broadly appear effective.
Clinical Insight
In patients with persistent neurocognitive or mood symptoms and a history of cat scratches/bites, Bartonella infection is likely underrecognized; order a Bartonella PCR (not just serology) and consider referral to a tick-borne disease–literate clinician, as antibody tests can miss intracellular, tissue-resident infections.
Actionable Takeaway
For patients (especially men) using tyrosine-containing supplements or very high-protein diets, obtain a fasting plasma tyrosine and phenylalanine panel (Quest/LabCorp) and review inflammatory markers; avoid or reduce tyrosine supplementation if levels are high or the tyrosine:phenylalanine ratio approaches/exceeds 10:1.
10. The Human Upgrade: Biohacking for Longevity & Performance
CDC Director Jim O’Neill on Fixing America’s Broken Food Policy : 1449
Published: 2026-04-14
URL: Listen Here
Summary
This episode features Jim O’Neill outlining an HHS/CDC push to overhaul U.S. food guidance and aging research while refocusing CDC on infectious diseases. Highlights include whole‑food, higher‑protein dietary guidance with forthcoming RCTs on saturated fat, large ARPA‑H investments in causal aging biomarkers and organ bioprinting, and greater openness to AI, wearables, non‑pharma therapies, and GLP‑1s. Several claims are policy announcements or opinions presented without primary citations.
Key Takeaways
The guest describes newly released federal dietary guidelines that emphasize whole and minimally processed foods, higher protein intake (1.2–1.6 g/kg/day), and allow meat and full‑fat dairy, while de-emphasizing refined grains and ultra‑processed foods; randomized controlled trials on saturated fats are being initiated.
HHS is prioritizing rigorous replication and aging science, including a reported $144M ARPA‑H initiative to identify causal biomarkers of aging and an organ bioprinting program that has printed a pediatric heart/vasculature (not yet implanted).
CDC is being refocused on infectious diseases, with examples cited of assisting to contain Ebola (DRC) and Marburg (Ethiopia), alongside a stated goal of rebuilding public trust through transparency.
There is openness to evaluating non‑pharmaceutical interventions (e.g., ozone therapy) with the same standards as drugs, and to integrating AI and wearables into care and surveillance—paired with strong patient consent and privacy protections.
Clinical and policy notes include support for GLP‑1s in obesity treatment, an ongoing review of upper vitamin D limits, and improvements to school meals aligned with the updated guidelines.
Clinical Insight
A shift toward whole‑food, higher‑protein nutrition with a more individualized view of dietary fats suggests clinicians should reassess grain‑centric, low‑fat counseling and focus on reducing ultra‑processed carbohydrates while tailoring fat and protein recommendations to each patient’s metabolic risk and goals.
Actionable Takeaway
For adult patients—especially those with metabolic syndrome risk or sarcopenia—calculate and document an individualized daily protein target of 1.2–1.6 g/kg from whole‑food sources, pair this with counseling to minimize ultra‑processed/refined carbohydrates, and reassess lipid/metabolic labs to tailor fat recommendations.
11. Huberman Lab
How Women Can Improve Their Fertility & Hormone Health | Dr. Natalie Crawford
Published: 2026-04-13
URL: Listen Here
Summary
Dr. Crawford details a proactive, science‑based roadmap for improving female fertility and hormone health: use AMH and ovulation tracking to detect issues early, leverage high‑impact lifestyle changes and targeted supplements during the “trimester zero,” and apply appropriate medical tools without waiting for failure. She emphasizes avoiding cannabis and nicotine, practical contraception off‑ramp timing, and clarifies that egg freezing/IVF do not reduce ovarian reserve, while highlighting select promising but still investigational therapies. Note: Summary reflects the provided transcript and may omit topics discussed outside these excerpts.
Key Takeaways
Proactive fertility assessment matters: Anti-Müllerian Hormone (AMH) testing estimates ovarian reserve (not egg quality) and can guide life and treatment planning; it’s inexpensive (~$79) and useful even before trying to conceive.
Track ovulation, not just periods: A luteal phase <11 days is an early red flag for ovulatory dysfunction; avoid NSAIDs except during menses because they can block follicle rupture and ovulation.
Lifestyle and exposures strongly influence fertility and hormone health: Prioritize sleep (7–9 h), stress control, muscle building, anti-inflammatory nutrition, and toxin minimization; avoid cannabis and nicotine (both sexes), which impair gametes and increase miscarriage risk.
Evidence-supported preconception supplements: Begin a prenatal (with folate), CoQ10, omega-3 fatty acids, and vitamin D; for male partners, add L‑carnitine (± zinc/selenium). Consider low-dose melatonin (1–3 mg) for sleep/inflammation preconception, then stop in pregnancy.
Clinical nuances: Egg freezing/IVF do not deplete ovarian reserve; stop combined OCPs 3–6 months before trying to learn ovulation, remove levonorgestrel IUD ~6 months before attempting conception, and avoid Depo‑Provera if planning pregnancy within 1–2 years. Selective, emerging tools (e.g., GLP‑1s in insulin resistance/inflammation, intrauterine PRP for implantation failure) show promise; ovarian PRP and red light remain investigational.
Clinical Insight
Replace the “fail‑first” model with an early, data‑driven approach: normalize AMH screening and ovulation/luteal‑phase tracking for reproductive‑age women to surface problems sooner and tailor timely lifestyle, medical, or procedural interventions that can materially improve outcomes.
Actionable Takeaway
At routine visits for women who might want children, offer AMH testing and brief ovulation‑tracking education, and initiate a 60–90‑day preconception plan: sleep 7–9 h; avoid cannabis/nicotine and NSAIDs outside menses; start prenatal (folate), CoQ10 (200–400 mg/day), omega‑3 (1–2 g/day EPA+DHA), vitamin D per level; counsel partners to add L‑carnitine (≈2 g/day); reassess promptly if luteal phase <11 days, cycles irregular, age ≥35, or ≥2 pregnancy losses.
12. The Human Upgrade: Biohacking for Longevity & Performance
CDC Director Jim O’Neill on Fixing America’s Broken Food Policy : 1449
Published: 2026-04-14
URL: Listen Here
Summary
Acting CDC Director Jim O’Neill outlines a pivot in U.S. food policy toward whole foods and away from ultra‑processed, grain‑heavy patterns, alongside active trials reassessing saturated fats. He details federal investments in causal aging biomarkers via ARPA‑H, broader acceptance of AI and wearables (with consent) in care, a renewed CDC focus on infectious diseases, support for GLP‑1s in obesity management, and a review of vitamin D limits. Several points reflect evolving policy announcements described in the interview.
Key Takeaways
HHS/CDC leadership reports newly announced U.S. dietary guidelines that emphasize whole, minimally processed foods, reduce reliance on grains and ultra-processed foods, and affirm that meat and full‑fat dairy can fit into a healthy diet; randomized controlled trials on saturated fats are underway.
The government is prioritizing replication and rigor, including a $144M ARPA-H initiative to develop and FDA‑validate causal biomarkers of aging to enable surrogate endpoints for prevention and longevity therapies.
CDC is refocusing on infectious disease and highlights recent collaborations that contained Ebola (DRC) and Marburg (Ethiopia), while rebuilding public trust via transparency and focus.
There is openness to testing non‑pharmaceutical and biohacking innovations (e.g., ozone therapy) with the same scientific standards, and expanded use of wearables and AI for early detection and clinical decision support, with strong emphasis on privacy and informed consent.
GLP‑1 receptor agonists are supported as effective tools for obesity when paired with nutrition and fitness, vitamin D upper‑limit recommendations are under review, and school meals are viewed as a high‑leverage point for improving national nutrition.
Clinical Insight
Expect a policy shift in federal nutrition guidance—toward whole, minimally processed foods with adequate protein and without blanket avoidance of saturated fat/full‑fat dairy—which, combined with GLP‑1 use where appropriate, can reshape counseling and management of obesity and cardiometabolic disease.
Actionable Takeaway
Update nutrition counseling now: guide patients to prioritize whole foods and minimize ultra‑processed/refined grains, target 1.2–1.6 g/kg/day protein, individualize recommendations on saturated fat based on cardiometabolic risk, and routinely measure 25‑OH vitamin D with supplementation as needed under monitoring.
13. The Human Upgrade: Biohacking for Longevity & Performance
1 Cup Every Morning Helped Me Lose 100 Pounds (Drink THIS) : 1452
Published: 2026-04-19
URL: Listen Here
Summary
This episode is a first‑person narrative promoting butter/MCT coffee, intermittent fasting, and a high‑fat, low‑grain approach while labeling common nutrition beliefs as myths and de‑emphasizing exercise for fat loss. It reflects popular biohacking perspectives but provides limited primary evidence; clinicians may encounter patients adopting these strategies and should contextualize them within current guidelines and individualized risk assessment.
Key Takeaways
Host Dave Asprey attributes losing over 100 pounds to starting mornings with “butter coffee” (grass‑fed butter + MCT oil) and practicing intermittent fasting, emphasizing satiety, steady energy, and reduced cravings.
He presents nine “myths” he believes hinder weight loss: saturated fat is harmful; low‑fat diets are healthy; calories‑in/calories‑out drives weight change; frequent small meals boost metabolism; all vegetables are beneficial (citing anti‑nutrients in some); whole grains are healthy; fruit is universally healthy (warns about fructose); breakfast is essential; and exercise is the primary tool for fat loss.
Asprey advocates prioritizing saturated fats from grass‑fed animal sources and coconut oil, avoiding trans fats and processed seed/vegetable oils, minimizing grains and high‑fructose fruits, and selecting lower anti‑nutrient vegetables.
He claims mold/mycotoxins in some coffees drive jitters and poorer tolerance, recommending “clean” coffee; he also argues diet quality and fasting outweigh exercise for fat loss and warns that overtraining may elevate cortisol.
The episode is largely anecdotal and promotional, referencing his books and commercial products; specific primary research citations supporting many claims are not provided.
Clinical Insight
Patients may inquire about high‑fat morning beverages and time‑restricted eating to curb hunger and aid weight management; clinicians should individualize guidance and, if trialed, monitor cardiometabolic risk (e.g., LDL‑C/apoB, glycemia, liver enzymes) given that several assertions—especially high saturated fat intake and broad avoidance of plant foods/grains—diverge from prevailing evidence‑based guidelines.
Actionable Takeaway
When patients ask about “butter coffee” or intermittent fasting, offer a short, supervised 2–4 week trial of time‑restricted eating (e.g., 14–16 hour daily fast) focused on minimally processed foods; advise non‑caloric morning beverages in higher‑risk patients, track hunger/weight/glucose, and recheck lipids as indicated before making longer‑term changes.
14. The Human Upgrade: Biohacking for Longevity & Performance
Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453
Published: 2026-04-21
URL: Listen Here
Summary
Jason Fung contends that contemporary obesity is driven primarily by hedonic and conditioned hunger magnified by ultra-processed foods and pervasive eating cues, not by a simple excess of calories. He outlines three rules—ditch ultra-processed foods, reintroduce fasting windows, and engineer environments—to lower hunger and make weight loss sustainable, positioning GLP‑1 medications as appetite-lowering tools to use alongside real‑food and behavior change.
Key Takeaways
Hunger has three distinct drivers—homeostatic (physical), hedonic (pleasure), and conditioned (cue-driven/social)—and the latter two dominate modern overeating.
Ultra-processed foods are engineered to maximize reward and minimize satiety (rapid absorption, texture modifiers, emulsifiers, flavor enhancers), amplifying hedonic and conditioned hunger independent of calories.
Sustained weight loss rarely results from calorie restriction alone; approaches that reduce hunger (diet quality, meal timing/fasting, environmental redesign) work better. GLP-1 receptor agonists help mainly by suppressing appetite but require concurrent habit change for durability.
Fung’s three golden rules: eliminate ultra-processed foods; include consistent fasting periods (reduce meal frequency/snacking); and redesign schedules/environments to remove eating cues and food noise.
Behavioral and mindset tools—such as extinction and counter-conditioning, eating only at a table, and reframing ultra-processed items as “not food”—can deprogram conditioned hunger and reduce cravings.
Clinical Insight
For patients with obesity, target hunger biology and conditioned cues rather than caloric math: assess and modify diet quality (real food over ultra-processed), structure meal timing (fasting windows), and reshape social/environmental triggers; consider GLP-1 agents to reduce appetite while concurrently coaching durable nutrition and behavioral skills.
Actionable Takeaway
At the next visit, screen for the three hunger types and initiate a 4‑week protocol: eliminate ultra-processed foods; eat 2–3 real‑food meals within an 8–10‑hour window with no calories between; and remove eating cues (no eating in the car/TV, keep snacks out of sight). If on a GLP‑1, pair with nutrition/behavioral coaching to build lasting habits.
15. The Human Upgrade: Biohacking for Longevity & Performance
Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453
Published: 2026-04-21
URL: Listen Here
Summary
This episode reframes obesity care around managing hunger biology and learned cues rather than prescribing calorie restriction. Fung explains how ultra-processed foods and ubiquitous food cues amplify hedonic and conditioned hunger, and outlines three practical rules—cut UPFs, add fasting windows, and redesign environments—to align physiology and behavior. GLP-1 medications can help by suppressing hunger, but sustained success depends on concurrent nutrition and behavioral retraining.
Key Takeaways
Overeating is primarily a hunger problem—not a calorie problem—with three contributors: homeostatic (physical), hedonic (pleasure-driven), and conditioned (cue-driven) hunger; in modern environments, conditioned and hedonic hunger dominate.
Ultra-processed foods are engineered to maximize reward (rapid absorption, intense flavors, optimized texture) while minimizing satiety, reinforcing both hedonic and conditioned hunger and driving habitual overconsumption.
Calorie restriction alone fails long term because physiology adapts and hunger intensifies; focusing on reducing hunger signals via food quality, structured fasting, and behavioral strategies is more sustainable.
GLP-1 receptor agonists reduce hunger and can enable weight loss, but durable results require concurrent learning of real-food eating patterns and environment/cue redesign to prevent relapse when medications stop.
Dr. Fung’s three golden rules: (1) eliminate ultra-processed foods; (2) establish consistent fasting windows and stop constant snacking; (3) redesign schedules and environments to reduce food cues, using counterconditioning and extinction to retrain conditioned hunger.
Clinical Insight
For sustained weight loss, clinicians should target the biology and behavior of hunger—especially conditioned and hedonic drivers—by replacing ultra-processed foods with real foods, implementing time-based fasting windows, and modifying environments/cues; pharmacologic appetite suppression (e.g., GLP-1 RAs) can be an adjunct but must be paired with nutrition and behavior change to maintain results.
Actionable Takeaway
Start a two-week intervention: advise patients to remove ultra-processed foods from home/work, eat 2–3 whole-food meals daily with adequate protein and natural fats, avoid between-meal snacks, and keep a 12–14-hour overnight fast; restrict eating to a table (not cars/TV) and replace evening snacking with unsweetened tea to extinguish conditioned cues, then reassess hunger/craving patterns at follow-up.
16. The Human Upgrade: Biohacking for Longevity & Performance
Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453
Published: 2026-04-21
URL: Listen Here
Summary
Dr. Jason Fung reframes weight loss around hunger biology and environment, arguing that hedonic and conditioned hunger—amplified by ultra-processed foods and pervasive cues—drive overeating more than true physical hunger. Sustainable management targets appetite regulation (real food, fasting windows, environment design, behavioral techniques) and may incorporate GLP-1 therapy as a tool while patients build lasting dietary and behavioral skills.
Key Takeaways
Obesity is driven by three types of hunger—homeostatic (physical), hedonic (pleasure-driven), and conditioned (social/cue-driven)—with conditioned and hedonic hunger now dominating due to environment, marketing, and constant food cues.
Chronic calorie restriction fails long-term because appetite and hormones (e.g., insulin, GLP-1 pathways) govern intake and expenditure; GLP-1 receptor agonists work by lowering hunger but require concurrent nutrition and behavior change for durable results.
Ultra-processed foods (UPFs) are engineered to maximize reward (rapid absorption, flavor enhancers, emulsifiers/texturizers) and minimize satiety, amplifying ‘food noise,’ cravings, and overeating; additives like carrageenan/xanthan gum can worsen mouthfeel-driven intake and may irritate the gut.
Fung’s three golden rules: (1) eliminate UPFs in favor of real, nutrient-dense foods; (2) ensure an adequate fasting window and stop constant snacking; (3) redesign schedule and environment (eat at a table, avoid eating while driving/TV, manage cues) to reduce conditioned hunger.
Behavioral strategies such as counterconditioning (pairing cravings with aversive imagery) and extinction/substitution (e.g., tea instead of snacks while watching TV), plus a mindset shift to view UPFs as “not food,” help deprogram conditioned eating.
Clinical Insight
Effective obesity care centers on diagnosing and treating hunger dysregulation (hedonic and conditioned drivers) and hormonal responses to food, not prescribing simple calorie restriction; prioritize removal of ultra-processed foods, structured fasting/eating windows, and environmental cue control, using GLP-1s as adjuncts to reduce hunger while patients learn durable eating behaviors.
Actionable Takeaway
Start a 2–4 week ‘real food + fasting’ trial: remove all ultra-processed items and sweetened/‘diet’ beverages; eat 2–3 real-food meals daily emphasizing protein and natural fats; maintain a 12–16 hour overnight fast with no snacking; and restrict eating to a table—then reassess hunger, satiety, and weight at follow-up.
17. The Human Upgrade: Biohacking for Longevity & Performance
Inside Kambo: Poison, Purging, and The People Who Swear By It : 1455
Published: 2026-04-24
URL: Listen Here
Summary
This episode examines Kambo’s traditional origins, modern ceremonial use, administration, peptide-based mechanisms, safety profile, and preliminary human outcomes. It highlights practical risk-reduction (especially electrolyte management), underscores the paucity of rigorous clinical data, and discusses sustainability and training standards relevant to clinicians advising patients exploring Kambo.
Key Takeaways
Kambo (frog skin secretion from Phyllomedusa bicolor) is applied via superficial skin burns and is not a classical psychedelic; it induces a rapid, intense 20–30 minute experience marked by flushing, tachycardia, nausea/vomiting, sweating, shaking, transient facial swelling (“frog face”), and possible bowel movements or syncope.
Traditional Amazonian use centered on ‘hunting magic’ (adaptogenic effects like heightened perception and stamina); modern practice emphasizes ritual, trauma work, and broad wellness aims, with anecdotal utility reported for pain, autoimmune issues, infections, metabolic disease, and addiction.
Pharmacology involves at least 27 peptide analogs across eight families (e.g., opioid-receptor–active and vagal-acting peptides, antimicrobial peptides) producing vascular, GI, autonomic, and possible antipsychotic effects; however, rigorous human research on the full Kambo cocktail is sparse.
Safety hinges on preventing hyponatremia from overhydration (especially when stacked with low-salt ayahuasca dieta/fasting) and supervising to mitigate aspiration and falls; with careful screening, electrolyte management, and close monitoring, serious adverse events appear uncommon.
Emerging data (practice datasets, a post-session survey, and a prospective human study pending publication) suggest improvements in mood, mindfulness, happiness, pain, and fatigue after Kambo; sustainability and standardization remain challenges, spurring conservation work and attempts to characterize/synthesize peptide mixtures.
Clinical Insight
Kambo is a peptide-rich, non-psychedelic intervention with meaningful autonomic, GI, antimicrobial, and opioid-receptor effects that may yield short-term improvements in mood, mindfulness, and pain—yet its safe application in practice depends primarily on rigorous screening and proactive electrolyte management to prevent hyponatremia.
Actionable Takeaway
If a patient plans to undergo Kambo, counsel them to avoid overhydration: use salted fluids or oral electrolyte solution (e.g., add 1/4–1/2 tsp sea salt per liter of water), avoid low-salt/fasting protocols and stacking with ayahuasca within 24–48 hours, and ensure the session is supervised by a trained practitioner who monitors for syncope/aspiration.
18. Huberman Lab
Male Roles, Obligations and Options for Building a Fulfilling Life | Scott Galloway
Published: 2026-04-27
URL: Listen Here
Summary
This episode examines modern male roles and well-being, advancing a positive masculinity framework (provider–protector–procreator plus service) and concrete habits that build purpose, skills, and relationships. It highlights Big Tech’s role in compulsive use and isolation, advocates for mentorship and national service, and outlines policy levers (antitrust, algorithmic liability, age-gating) and personal behaviors clinicians can reinforce to improve mental health and social outcomes.
Key Takeaways
Galloway proposes a constructive masculinity code—provider, protector, procreator—augmented by service and the goal of creating “surplus value” (giving more than one takes).
Practical plan for struggling young men: reclaim screen time; train hard (≥3x/week); work outside the home (~30 hrs/week when feasible); engage weekly in team/service groups; and practice graded social “approaches,” embracing rejection as a skill-builder.
Big Tech and algorithmic feeds foster compulsive phone use, isolation, and polarization; policy remedies discussed include antitrust actions, algorithmic liability (Section 230 reform), and age-gating social media for minors.
Male mentorship and (ideally) national service are framed as high-yield solutions to purpose, skill development, and social cohesion—especially critical for boys lacking an involved male role model.
Societal/economic context matters: wealth transfer from young to old, higher-ed gatekeeping, and limited vocational on-ramps are linked to male underachievement and relationship/fertility headwinds; clinicians should recognize porn overuse as an under-researched, potentially demotivating behavior, while alcohol/THC can be net harmful or helpful depending on context and use patterns.
Clinical Insight
For young and midlife men, social isolation coupled with compulsive digital use (better conceptualized as an OCD-like compulsion loop than simple ‘dopamine hits’) is a potent driver of anxiety, depression, and suicidality; brief clinical screening and counseling that redirect time toward structured exercise, out-of-home work/school, service/mentorship, and graded real-world social engagement can meaningfully improve mental health and functioning.
Actionable Takeaway
In visits with adolescent and young adult males, add a 4-point screen—1) daily screen time and app limits, 2) exercise ≥3 days/week (resistance and/or endurance), 3) hours spent working or studying outside the home, 4) weekly group/service participation—then prescribe a 2–4 week trial to reallocate at least 8 hours/week from phone use to those activities and provide a mentorship or Big Brothers Big Sisters referral if a stable male role model is lacking.
19. The Human Upgrade: Biohacking for Longevity & Performance
The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458
Published: 2026-04-30
URL: Listen Here
Summary
This episode outlines how EWOT and red/near-infrared light therapy can be mechanistically complementary: exercise-driven hyperoxia improves oxygen delivery while PBM increases mitochondrial oxygen demand and nitric oxide–mediated microvascular perfusion. The approach targets endothelial and mitochondrial dysfunction implicated in fatigue, chronic inflammation, and recovery limitations, with a practical protocol of 15 minutes of EWOT followed by immediate PBM. Few specific clinical trials were cited during the conversation; recommendations were largely mechanistic and experiential.
Key Takeaways
Exercise with Oxygen Therapy (EWOT) delivers ~93% oxygen during 10–15 minutes of light-to-moderate exercise using a concentrator and large reservoir bag, leveraging exercise-induced increases in ventilation, heart rate, vasodilation, and pressure gradients to drive oxygen deeper into tissues than resting oxygen supplementation.
Chronic inflammation and endothelial dysfunction impair microcirculation (pseudo-hypoxia) even when pulse oximetry is normal; swollen endothelial cells and less-flexible RBCs limit capillary oxygen delivery, pushing cells toward anaerobic metabolism, ROS production, and a self-reinforcing inflammatory loop.
Red/near-infrared photobiomodulation (PBM) enhances mitochondrial function by increasing oxygen demand and releasing nitric oxide for vasodilation; stacking PBM immediately after EWOT (when circulation and tissue oxygen levels are elevated) amplifies outcomes (energy, sleep, pain, recovery).
A practical stack advocated: ~15 minutes of EWOT followed immediately by 10–20 minutes of red/NIR light (multiple red and NIR wavelengths) targeted to symptomatic areas or whole body to pair oxygen supply with mitochondrial uptake.
Potential use cases discussed include fatigue, long-COVID/lung injury, endothelial and microvascular dysfunction, ‘anaerobic’ infections (e.g., Lyme), and detox support; the episode’s claims were primarily mechanistic and experiential, with few specific trials cited.
Clinical Insight
Tissue-level hypoxia from microvascular/endothelial dysfunction can persist despite normal SpO2; combining EWOT to enhance oxygen delivery with photobiomodulation to increase mitochondrial oxygen utilization and nitric oxide–mediated perfusion may help break cycles of low energy, inflammation, and impaired recovery.
Actionable Takeaway
For appropriate patients, trial a stacked protocol: 10–15 minutes of moderate EWOT (reservoir-fed ~93% FiO2) followed immediately by 10–15 minutes of red/NIR photobiomodulation (e.g., 620–660 nm and 800–1050 nm) targeted to key regions (e.g., lungs, neck/shoulders, lower limbs), while monitoring HR/BP/SpO2 and tracking functional markers (symptoms, 6MWT/VO2 proxy, and if available pulse wave velocity). Screen for contraindications to high FiO2 and follow oxygen safety protocols.
20. The Human Upgrade: Biohacking for Longevity & Performance
The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458
Published: 2026-04-30
URL: Listen Here
Summary
This episode explores how EWOT and red/near-infrared light target complementary sides of cellular energetics: EWOT boosts oxygen delivery during exercise, while photobiomodulation increases mitochondrial oxygen use and nitric oxide signaling. By addressing endothelial/microcirculatory dysfunction and mitochondrial inefficiency—common in aging and chronic disease—the combined approach may enhance energy, recovery, and vascular health, with practical protocols feasible at home.
Key Takeaways
Exercise with Oxygen Therapy (EWOT) uses a concentrator and large reservoir to deliver ~93% oxygen during 15 minutes of moderate exercise, leveraging exercise-induced vasodilation and pressure gradients to drive oxygen deeper into hypoxic tissues.
Aging and chronic illness often feature microcirculatory dysfunction and endothelial swelling that block red blood cells from reaching capillaries, creating tissue-level “pseudo-hypoxia” despite normal pulse oximetry; mitochondria then shift to low-yield anaerobic metabolism with more inflammatory byproducts.
Red/near-infrared light (photobiomodulation) complements EWOT by increasing mitochondrial oxygen demand and efficiency (e.g., cytochrome c oxidase effects) and by promoting nitric oxide–mediated vasodilation, improving energy production and microvascular function.
Stacking protocol: complete a 15-minute EWOT session, then immediately apply red/near-IR light (10–15 minutes) to capitalize on elevated circulation and oxygen availability; simultaneous use is possible but less practical.
Discussed benefits include improved energy, sleep, pain, skin quality, recovery, and potential support in conditions with microvascular/mitochondrial dysfunction (e.g., Lyme, post-viral/long-COVID lungs), along with practical access to home EWOT systems and broad-spectrum red/IR devices.
Clinical Insight
Tissue hypoxia from microvascular and endothelial dysfunction can persist with normal SpO2 and underlies many chronic symptoms; combining strategies that enhance oxygen delivery (EWOT) with those that increase mitochondrial oxygen utilization and nitric oxide–driven vasodilation (red/near-IR light) may restore cellular energy and improve function in select patients.
Actionable Takeaway
For appropriately screened patients, implement a stack 3–5 times weekly: 15 minutes of EWOT at moderate exertion using a reservoir-fed concentrator (~93% O2), followed immediately by 10–15 minutes of red/near-IR photobiomodulation directed to priority regions (e.g., thorax for lung issues or large muscle groups); track response via symptoms (energy, sleep, pain) and, when available, vascular metrics (e.g., pulse wave velocity).
21. The Human Upgrade: Biohacking for Longevity & Performance
The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458
Published: 2026-04-30
URL: Listen Here
Summary
This episode explains how EWOT and red/near‑infrared light therapy can be combined to address mitochondrial dysfunction and microcirculatory ‘pseudo-hypoxia’ that underlie many chronic symptoms. The discussion emphasizes endothelial health, nitric oxide–mediated vasodilation, arterial stiffness (pulse wave velocity), and the lung’s role in detoxification, offering a practical sequencing strategy (EWOT, then PBM) to enhance energy, recovery, and tissue oxygenation. Limitations: the conversation is expert opinion–heavy and promotional in parts, and does not cite specific peer‑reviewed studies.
Key Takeaways
Exercise with oxygen therapy (EWOT) uses a concentrator and large reservoir (~93% O2) to deliver high oxygen flow during 10–15 minutes of moderate exercise, leveraging exercise-induced vasodilation and pressure gradients to drive oxygen deeper into tissues.
Stacking red/near-infrared photobiomodulation (PBM) immediately after EWOT exploits elevated circulation and oxygen availability to increase mitochondrial oxygen demand and efficiency, enhancing energy production, recovery, pain relief, and potentially sleep, skin, and sexual function via nitric oxide signaling.
Endothelial health and microcirculation are central: inflammation causes endothelial swelling and reduced RBC deformability, creating ‘pseudo-hypoxia’ (normal SpO2 but poor tissue oxygenation) that shifts mitochondria to inefficient anaerobic metabolism and a pro-inflammatory ‘doom loop.’
Arterial stiffness is an aging biomarker (e.g., pulse wave velocity); exercise and PBM can increase nitric oxide, improve vasodilation, and may support arterial flexibility and downstream tissue oxygenation.
Lungs are major detox organs (~70% of toxin elimination); adequate oxygen is required for biotransformation and repair. EWOT may support recovery in post-viral/lung injury states by improving cellular oxygenation and mitochondrial energy needed for healing.
Clinical Insight
Sequenced therapy—EWOT to rapidly elevate tissue oxygen supply followed immediately by PBM to raise mitochondrial oxygen demand—can help overcome tissue-level ‘pseudo-hypoxia,’ restore aerobic metabolism, and improve microcirculatory function in patients with chronic inflammation, endothelial dysfunction, or post-illness fatigue.
Actionable Takeaway
Implement a clinic protocol: 10–15 minutes of EWOT (reservoir-fed ~93% O2) at moderate intensity (elevated HR/respiratory rate) followed within 5 minutes by 10–20 minutes of PBM (combined red ~630–680 nm and near-infrared ~800–1050 nm) targeted to symptomatic regions (e.g., thorax for lung, large muscle groups, or generalized exposure). Monitor SpO2/HR/BP, start with conservative dosing, and track outcomes (e.g., 6MWT, symptom scores, VO2 max trend, pulse wave velocity/microvascular assessments). Screen for photosensitizing meds and cardio-pulmonary contraindications.
22. Health Longevity Secrets
Your Phone Is Rewriting Your Biology — Daniel DeBaun (Former Bell Labs Engineer)
Published: 2026-05-05
URL: Listen Here
Summary
Telecom engineer Daniel DeBaun argues that everyday non-ionizing EMFs from phones, Wi‑Fi, and emerging 5G/6G can affect human biology despite compliance with thermal-based exposure limits, citing animal evidence (NTP, Ramazzini), rising EHS reports, and potential shortcomings of 1990s-era FCC guidelines. The episode emphasizes feasible risk-reduction steps—maximize distance, minimize duration, prefer wired connections, and use selective shielding—while highlighting major research gaps at higher frequencies and the need for larger, better-funded human studies. Some claims remain debated in the broader scientific community, and a few details in the discussion lack specific citations.
Key Takeaways
Non-ionizing EMFs (ELF, RF/microwave, and blue light) can exert biological effects beyond heating, with proposed impacts on the blood–brain barrier, gut microbiome, fertility, and other soft tissues.
Risk appears related to proximity, intensity, duration, and cumulative load of devices; heavy, long-term cell phone use is associated in some studies with increased frontal-lobe tumors, and reports of electrohypersensitivity (EHS) symptoms are rising.
Current FCC SAR-based exposure limits (1.6 W/kg) were designed around 1990s thermal models and adult males; they may not reflect contemporary usage patterns, children’s vulnerability, or higher-frequency 5G/6G scenarios.
Large animal studies (NTP, Ramazzini) reported increased tumors with chronic RFR exposure, while human causal evidence remains limited; meta-analyses/metadata reviews suggest concern but uncertainties persist.
Practical mitigation focuses on distance and time reduction, favoring wired over wireless at home, limiting on-body device carriage (especially for head and pelvis), nighttime exposure reduction, and selective shielding directed away from the body.
Clinical Insight
Consider EMF exposure as a modifiable environmental factor when evaluating nonspecific neurologic, sleep, stress-related, or fertility concerns—especially in children and pregnancy—and incorporate a brief exposure history with counseling on distance/time reduction and home mitigation strategies.
Actionable Takeaway
Add a 60-second EMF screen to routine visits and advise patients to keep phones off the body and away from the head (use speakerphone or a wired headset), avoid bedside phone use/charging, disable Wi‑Fi/Bluetooth when not needed (particularly overnight), and preferentially use wired internet at home.
23. Docs Who Lift
Heavy Metal Toxicity: Separating Real Risks From Influencer Scams | Dr. Eryn Russo
Published: 2026-05-05
URL: Listen Here
Summary
This episode with preventive/occupational/environmental medicine specialist Dr. Eryn Russo delineates legitimate heavy metal toxicology from influencer-driven misinformation. It details how to properly evaluate suspected exposures, clarifies real risks and appropriate testing for lead, mercury, cadmium, arsenic, and hexavalent chromium, and explains why online detoxes/chelation are inappropriate or dangerous for most patients. Public health standards generally protect the population, and clinicians should focus on exposure-informed, evidence-based care.
Key Takeaways
Influencer-driven heavy metal toxicity claims commonly rely on non-validated tests—especially ‘provoked’ urine testing—and upsell unproven detoxes or chelation; this is misleading and potentially harmful.
Proper assessment hinges on a detailed exposure history (source, dose, duration, route), consideration of occupational/environmental measurements (e.g., industrial hygiene air sampling), and targeted biologic monitoring; vague symptoms like brain fog or fatigue rarely indicate heavy metal poisoning.
Real hazards include lead, mercury, cadmium, arsenic, and hexavalent chromium—each with specific sources, organ targets, and appropriate tests: blood lead; mercury speciation with blood for organic forms and urine for inorganic forms (plus renal markers); cadmium in blood and urine with creatinine correction and beta-2 microglobulin; arsenic speciation to quantify inorganic forms; no validated blood/urine assay for Cr(VI); organ system surveillance (renal, pulmonary, hematologic, neurologic, dermatologic) is often required.
Chelation is a high-risk medical therapy with electrolyte and renal complications and should be reserved for clearly defined indications; notably, the guest has not needed chelation once in 20 years of treating genuinely exposed workers.
Population protections (OSHA/EPA standards, Safe Drinking Water Act) and NHANES data show generally safe or declining exposures; common concerns such as dental amalgam, thimerosal in vaccines (removed or non-toxic ethylmercury), typical farmed fish intake, and plant protein products within regulatory limits are not major risks when guidance is followed.
Clinical Insight
In patients with suspected heavy metal exposure, anchor decisions to a structured exposure history and metal- and route-specific testing (including appropriate specimen and speciation) rather than nonspecific symptom clusters or non-validated panels; reserve chelation for guideline-defined toxicity due to its potential harms.
Actionable Takeaway
When a patient presents influencer-ordered ‘heavy metal’ results and nonspecific symptoms, perform a structured occupational/environmental exposure history (work, hobbies, diet, water source, residence, dose/duration/route), and if warranted order evidence-based tests (e.g., blood lead; mercury speciation with blood for organic and urine for inorganic forms; cadmium in blood/urine with creatinine correction and beta-2 microglobulin; arsenic speciation). Explicitly avoid ‘provoked’ urine testing and counsel patients about its invalidity.
24. Lifespan with Dr. David Sinclair
What To Do For Longevity | Lifespan with Dr. David Sinclair Rewind
Published: 2026-05-06
URL: Listen Here
Summary
This episode distills practical longevity strategies emphasizing consistency over complexity: eat less often, cut added sugar, favor a Mediterranean/plant-forward pattern with moderated protein (especially limiting red/processed meat), and pair this with daily movement, vigorous exercise, resistance training, thermal hormesis, and robust sleep/circadian habits. Sinclair underscores measurement (wearables, smart scales, select labs) and discusses investigational molecules (e.g., NMN, resveratrol, metformin) that target nutrient-sensing pathways, noting that behavioral foundations remain primary for healthspan and lifespan.
Key Takeaways
Eat less often via time-restricted eating (e.g., ≥16-hour fasts) and avoid snacking; prioritize low-sugar intake and, when meals are eaten, consume protein/fat first and carbohydrates last to blunt postprandial glucose spikes.
Adopt a plant-forward Mediterranean-style diet (olive oil, vegetables, legumes, nuts, whole grains) and limit red/processed meats to reduce TMAO-related cardiovascular risk and chronic mTOR activation; ensure B12 (and other B vitamins) adequacy if largely plant-based.
Exercise is medicine: accumulate daily movement plus ~75 minutes/week of vigorous activity and regular resistance training to lower all-cause, cardiovascular, and cancer risk and to slow biological aging; track resting heart rate and HRV as simple fitness markers.
Strategic hormesis (sauna heat exposure and cold exposure) may trigger protective pathways (e.g., heat-shock proteins, brown fat activation/mitochondrial adaptations) and complements diet and exercise; starting in midlife can enhance later-life benefits.
Measure and personalize: use wearables and smart scales to monitor sleep, recovery, body composition and inflammation proxies; prioritize sleep and circadian alignment (morning light, evening wind-down) to support longevity pathways (AMPK/mTOR/sirtuins).
Clinical Insight
Consistent, low-complexity lifestyle patterns—16:8 time-restricted eating with low added sugar, a Mediterranean-style diet low in red/processed meats, and combined aerobic plus resistance training—convergently engage AMPK, mTOR, and sirtuin pathways, lowering cardiometabolic and cancer risk and measurably slowing biological aging (e.g., epigenetic clocks).
Actionable Takeaway
Offer eligible adults a 4-week 16:8 time-restricted eating trial: allow water/unsweetened coffee/tea during the 16-hour fast; break the fast with protein/fat and consume carbohydrates last; eliminate sugar-sweetened beverages; use a small handful of nuts to curb hunger if needed; track weight, waist-to-height ratio (<0.5), and glucose trends (fasting or CGM) to assess tolerance and benefit.
25. The Human Upgrade: Biohacking for Longevity & Performance
Eat These Foods + Spices for 8 Weeks To Get 3 Years Younger | Kara Fitzgerald : 1461
Published: 2026-05-05
URL: Listen Here
Summary
This episode discusses how epigenetic targeting—especially via polyphenol‑rich, methylation‑supportive nutrition—can reduce biological age, highlighting a pilot RCT showing >3‑year reduction in 8 weeks and follow‑up analyses implicating nutrients as primary drivers. It also explores Yamanaka factors, PRC2‑based ‘programmatic aging’ measures, and candidate nutrient mimetics, alongside practical monitoring with methylation clocks. Findings are promising but derive from small, multimodal trials and require replication and standardization before broad adoption.
Key Takeaways
An 8-week randomized controlled diet/lifestyle program emphasizing methyl donors and polyphenol-rich ‘methylation adaptogens’ reduced Horvath clock biological age by >3 years in healthy middle-aged men; subsequent analyses pointed to nutrient/polyphenol intake as the primary driver.
Dietary polyphenols (e.g., EGCG; herbs like rosemary, oregano, marjoram, thyme) modulate DNA methylation and gene expression; combining a diverse, polyphenol-dense diet with select, bioavailable supplements (e.g., urolithin A) may achieve therapeutic effects not always attainable from food alone.
Emerging ‘Yamanaka mimetics’ (e.g., alpha‑ketoglutarate, sodium butyrate, forskolin) and PRC2/Polycomb-based indices may target programmatic aspects of aging beyond exposomic wear-and-tear captured by later-generation clocks.
Transient OSK (Yamanaka) reprogramming has reversed age-related phenotypes in preclinical models (e.g., optic neuropathy, skin), but human translation remains early and requires tight control to avoid risks.
Biological age tracking tools (Horvath clock, DunedinPACE) and AI-augmented imaging can help personalize longevity care; diet quality and methylation support appear foundational across sexes, with women showing favorable responses in case series.
Clinical Insight
A targeted, polyphenol-dense, methylation-supportive nutrition pattern can measurably lower epigenetic age within weeks, with evidence that specific polyphenols (rather than exercise alone) are key effectors—making methylation clocks practical tools to track response in midlife patients.
Actionable Takeaway
Initiate an 8‑week methylation-supportive plan: prioritize 7–11 cups/day of diverse vegetables, herbs, and spices (e.g., green tea/EGCG, rosemary, oregano, marjoram, thyme), plus quality protein and healthy fats; obtain a baseline DNA‑methylation age (e.g., DunedinPACE) and repeat at 8 weeks to assess impact.
26. The Second Opinion Podcast with Dr. Paul Kolodzik
EP 118 - EP 118: Navigating New GLP-1 Costs and Pharmacist Consultations with Dr. Paul Kolodzik
Published: 2026-05-07
URL: Listen Here
Summary
This episode explains how GLP-1 therapies are becoming more accessible through a new Medicare Part D Bridge Program and rapidly declining out-of-pocket prices, with practical details on eligibility, prior authorization, and typical monthly costs. The hosts emphasize pharmacist consultations and integrated lifestyle strategies (protein, resistance training, low-carb eating, CGM) to optimize results, limit lean mass loss, and reduce required doses. They also note evolving rules around compounding and the emergence of generics abroad, while cautioning that some pipeline timelines and product names discussed were conversational.
Key Takeaways
Medicare Part D will launch a temporary GLP-1 Bridge Program (starting July 2026) offering obesity treatment coverage with an estimated $50/month copay, prior authorization required, and eligibility based on BMI ≥35 or BMI ≥27 with comorbidities.
Out-of-pocket prices for brand GLP-1s have fallen markedly versus prior years (~$1,200/month): Zepbound ~$299–$450/month; Wegovy injectable ~$200 initially then ~$350; oral semaglutide ~$149 for initiation then ~$250, with costs potentially dropping again if doses are reduced.
Dedicated pharmacist consultations can significantly improve medication use (e.g., aligning pre-meal insulin timing with pharmacokinetics), often yielding better control than brief physician visits alone.
Optimal GLP-1 care should include high-protein intake, resistance training, low-carbohydrate nutrition, selective time-restricted eating (14–16 hours), and consideration of CGM to preserve lean mass, enhance outcomes, and enable dose-sparing; approximately 10% may be genetic low/non-responders.
Regulatory landscape is shifting: manufacturer discounts often exclude Medicare/Medicaid; FDA is moving to curb mass compounding of semaglutide/tirzepatide as shortages ease; some countries now have generic semaglutide, but importation into the U.S. is illegal.
Clinical Insight
Expanded Medicare access to GLP-1 therapy via the Bridge Program can make effective obesity treatment feasible for many older adults, but clinical success and safety hinge on coordinated, multidisciplinary management (pharmacist input, nutrition, and strength training) rather than medication alone.
Actionable Takeaway
Proactively identify Medicare Part D patients who meet BMI/comorbidity criteria and begin preparing/submitting prior authorizations now for GLP-1 coverage under the forthcoming Bridge Program.
27. The Human Upgrade: Biohacking for Longevity & Performance
Eat These Foods + Spices for 8 Weeks To Get 3 Years Younger | Kara Fitzgerald : 1461
Published: 2026-05-05
URL: Listen Here
Summary
This episode highlights clinical and mechanistic evidence that diet rich in methyl donors and polyphenols—supported by foundational lifestyle practices—can reverse epigenetic age within weeks, with nutrients doing the ‘heavy lifting.’ It also explores the frontier of Yamanaka factor biology and PRC2-linked ‘programmatic’ aging, proposing that select polyphenols may partially mimic reprogramming effects. Limitations include multimodal design (potential confounding), reliance on specific clocks, and that ‘Yamanaka mimetic’ strategies are largely preclinical.
Key Takeaways
An 8-week randomized controlled dietary and lifestyle program emphasizing methyl-donor foods and polyphenol-rich ‘methylation adaptogens’ reduced biological age by over three years on the Horvath epigenetic clock in healthy middle-aged men; subsequent analysis suggested nutrients—especially dense polyphenols—were the primary drivers.
The protocol featured 7–11 cups/day of fruits, vegetables, herbs, and spices; methylation-supportive foods (e.g., leafy greens, eggs, beets, liver); and included meditation, sleep hygiene, and exercise, with the control group’s exercise likely making exercise effects a wash.
Polyphenols (e.g., EGCG from green tea; culinary herbs like rosemary, oregano, marjoram, thyme; and targeted options like urolithin A) may modulate gene expression and epigenetic marks; supplements can layer on top of diet for therapeutic dosing, though diet provides synergistic ‘information’ not captured by single compounds.
Emerging work on Yamanaka factors and polycomb repressive complex 2 (PRC2) suggests a ‘programmatic’ component of aging; early evidence indicates caloric restriction and potentially select polyphenols could act as ‘Yamanaka mimetics’ to nudge youthful epigenetic programs (largely preclinical at present).
First-generation clocks (e.g., Horvath) may capture aspects of programmatic aging; newer measures (e.g., DunedinPACE) are useful for tracking pace of aging. Case reports indicate women can also achieve meaningful bioage improvements with similar nutrition-forward protocols.
Clinical Insight
A targeted, food-first intervention emphasizing methyl-donor nutrients and high–polyphenol intake—augmented by basic lifestyle practices—can measurably and rapidly lower epigenetic age; in this cohort, the nutritional components appeared to account for most of the effect.
Actionable Takeaway
Implement an 8-week methylation-supportive nutrition plan (7–11 cups/day of diverse plants and polyphenol-rich herbs/spices; plus methyl donors like leafy greens, eggs, beets, and liver), alongside meditation and sleep hygiene; consider layering targeted polyphenol and metabolic supplements (e.g., EGCG, urolithin A, alpha‑ketoglutarate, sodium butyrate) as appropriate, and measure epigenetic age (e.g., Horvath/DunedinPACE) pre- and post-intervention to assess impact.
28. The Human Upgrade: Biohacking for Longevity & Performance
iPhone Poisoning Is REAL: Here’s How To Reverse the Hidden Damage | Quantum Upgrade : 1462
Published: 2026-05-07
URL: Listen Here
Summary
This episode promotes a remote ‘quantum energy’ service claimed to mitigate EMF-related physiologic stress and enhance various biomarkers, with applications spanning humans, pets, and environmental spaces. While numerous measurements and anecdotes are described, specific peer‑reviewed publications, methods, and mechanisms are not provided; for medical practice, it highlights growing patient interest in bioenergetic technologies and the importance of evidence-based counseling about EMF exposure and validated health interventions.
Key Takeaways
The episode features “Quantum Upgrade,” a remote, user-controlled ‘quantum field’ service that claims to deliver customizable frequency sets (e.g., Heal360, Gratitude, Spectrum, athletic performance) to people, pets, vehicles, and locations.
Guest claims the service measurably reduces EMF-related physiologic stress, citing internal/third-party data: 256‑channel EEG changes (reduced stress-linked brainwaves; 13× increase in limbic alpha during phone exposure), HRV improvements, dark-field blood microscopy, ATP production, and cell wound-healing assays.
Modern EMF exposures (5G/6G, 60 GHz in-cabin radar, Starlink) are portrayed as biologically disruptive; the product is said to ‘harmonize’ rather than block fields to mitigate effects, including for children who are described as particularly vulnerable.
Autism-related claims include a clinic study of 42 children with reported reductions in an autism scoring metric over six months using earlier tech, and collaboration with Susie Miller to refine a ‘Spectrum’ frequency and a ‘Creativity Support’ frequency for parents.
Much of the evidence discussed is unpublished, lacks detailed peer‑reviewed citations, and relies on nonstandard diagnostics (e.g., dark-field microscopy, BESA/EAV methods), television demonstrations, testimonials, and internal reports; a 15‑day free trial is promoted.
Clinical Insight
Patients may present interest in remote ‘quantum’ energy services to address EMF-related symptoms and neurodevelopmental concerns; clinicians should appraise such claims critically, differentiate them from consensus evidence, and guide patients toward validated exposure mitigation and outcome tracking while avoiding endorsement of unproven modalities.
Actionable Takeaway
Routinely screen for high screen/device use, nighttime device proximity, and blue-light exposure—especially in children with sleep, attention, anxiety, or headache complaints—and offer evidence-based mitigation (limit screen time, use speaker/air‑tube headsets, keep devices off the body at night, enable night modes/blue‑light filters, optimize sleep hygiene), documenting baseline and follow-up outcomes (sleep quality, symptoms, standardized scales) if patients choose complementary tools.
29. Health Longevity Secrets
EXPLAINER: 3 Blood Tests Your Doctor Skips (That Predict Heart Attacks & Alzheimer’s)
Published: 2026-05-07
URL: Listen Here
Summary
This episode argues that fasting insulin/HOMA-IR, homocysteine, and hsCRP outperform standard cholesterol and glucose testing for predicting cardiometabolic and neurodegenerative risk, often years earlier. It synthesizes epidemiologic and trial data to recommend routine adoption of these inexpensive markers to catch insulin resistance, impaired methylation, and inflammation upstream and guide preventive interventions.
Key Takeaways
Three low-cost, widely available labs—fasting insulin (with HOMA-IR), homocysteine, and high-sensitivity C-reactive protein (hsCRP)—often predict cardiovascular events, type 2 diabetes, and dementia risk better than standard lipid and glucose panels.
Insulin resistance can exist for 10–15 years with normal glucose and cholesterol; fasting insulin and HOMA-IR detect this early and are linked to substantially higher cardiovascular incidence and mortality, even in non-obese individuals.
Elevated homocysteine independently damages endothelium and is associated with higher risks of coronary disease, stroke, and Alzheimer’s disease; risk begins to rise above ~10 µmol/L, with optimal <8 µmol/L.
Inflammation drives atherosclerosis; hsCRP outperforms LDL in predicting major cardiovascular events in large cohorts, and statin therapy in people with normal LDL but elevated hsCRP (≥2 mg/L) significantly reduces events (JUPITER trial).
‘Optimal’ targets cited: fasting insulin <5–8 µIU/mL, homocysteine <8 µmol/L, hsCRP <1 mg/L; adding these tests (~$60 total) improves upstream detection of metabolic dysfunction beyond a lipid panel.
Clinical Insight
Incorporating fasting insulin/HOMA-IR, homocysteine, and hsCRP into routine risk assessment materially improves early identification of metabolic dysfunction and inflammatory risk, enabling earlier, more targeted prevention than cholesterol or glucose testing alone.
Actionable Takeaway
At the next cardiovascular risk evaluation, add fasting insulin (with simultaneous fasting glucose to calculate HOMA-IR), homocysteine, and hsCRP; use episode-cited thresholds to guide action (fasting insulin <5–8 µIU/mL, homocysteine <8 µmol/L—treat elevations with methylfolate, methylcobalamin, and B6; hsCRP <1 mg/L—address inflammatory drivers and consider guideline-based therapy).
30. Huberman Lab
Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern
Published: 2026-05-07
URL: Listen Here
Summary
This episode outlines how compulsive behaviors arise from dysregulated ventral striatal circuits and reviews the current and emerging roles of DBS, TMS, and MRI-guided focused ultrasound in treating refractory OCD, addiction, and eating disorders. It emphasizes first-line therapies (SSRIs/tricyclics and ERP), realistic expectations for neurosurgical options, and ongoing research using invasive recordings, mood provocation, and AI/ML to personalize targets and timing of interventions. Note: As an Essentials edit, procedural details and patient selection criteria are condensed.
Key Takeaways
Deep brain stimulation (DBS) delivers targeted electrical therapy via implanted electrodes and can produce immediate symptom relief in movement disorders; transient limbic effects (e.g., laughter, panic) during mapping reveal circuit-specific opportunities to treat mood and compulsive symptoms.
OCD care begins with pharmacotherapy (high-dose SSRIs and/or tricyclics like clomipramine) and exposure and response prevention (ERP); ~30% remain refractory, and neurosurgical options (DBS or capsulotomy) can help a subset, with typic.
Stay connected with Dr Onyx MD PhD for clinical insights and wellness tools that bridge science and everyday care:
Instagram ✦ X (Twitter) ✦ LinkedIn ✦ Website
From Insights to Action
Knowledge without execution changes nothing. The insights above only reach their full potential when integrated into a strategic, personalized plan. That’s where two offerings come in:
Personalized Medical AI Chatbot
Healthcare complexity is overwhelming. Clinical studies, conflicting guidelines, and fragmented records leave most patients paralyzed.
Deploy your Dr Onyx MD PhD Medical AI Chatbot—a personalized architecture that synthesizes your medical history, the latest research, and your unique condition into clear, actionable insights.
It’s not a replacement for your doctors—it’s your secret weapon for making better decisions and becoming the CEO of your own care.
👉 Deploy your Medical AI Chatbot today and take control of your health narrative
Premium Longevity Program
For people who know their most valuable asset is their health.
This year-long partnership delivers clarity, accountability, and physician-led execution. Stop collecting fragmented data and start acting on a ranked, strategic plan tailored to your biology and lifestyle.
👉 Discover the Premium Longevity Program and secure your health as your ultimate investment.